HC Wainwright & Co. Initiates Coverage On Lakewood-Amedex with Buy Rating, Announces Price Target of $3
Benzinga Newsdesk 3 days ago
Analyst RatingsNewsInitiationPrice Target
HC Wainwright & Co. analyst Matthew Keller initiates coverage on Lakewood-Amedex (NASDAQ:LABT) with a Buy rating and announces Price Target of $3.
HC Wainwright & Co. analyst Matthew Keller initiates coverage on Lakewood-Amedex (NASDAQ:LABT) with a Buy rating and announces Price Target of $3.